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3-Acetyl-2-methyl-I,8-naphthyridine 1 on treatment with different isatins 2 gives the
corresponding 3-hydroxy-3-(2-methyl-I,8-naphthyridine-3-carbonylmethy1)-indole-2-ones 3, which on
dehydration afford the substituted 3-(2-methyl-1 ,8-naphthyridine-3-carbonyl-methylene )-indole-2-ones
4. Cyc1ocondensation of 4 with hydrazine hydrate, phenylhydrazine, urea, thiourea and 0-
phenylenediamine afford novel spiro[indole-pyrazolines] 5 and 6, spiro [indole-pyrimidinones] 7,
spiro[indole-pyrimidinethiones] 8 and spiro[indole-l ,5-benzodiazepines] 9 containing 1,8-naphthyridine
moiety, respectively. The structures of the compounds 3-9 have been established on the basis of their
elemental analyses and spectral (IR, 'n NMR and mass) data. The compounds 4, 6 and 8 have been
tested for their antibacterial activity.
The discovery of nalidixic acid (3-carboxy-l-
ethyl-7-methyl-l, 8-naphthyridin-4-one) in the
treatment of chronic urinary tract infections has
created a great impetus in I, 8-naphthyridine
derivatives as antibacterial agents I. Some I, 8-
naphthyridines exhibit marked diuretic',
antimalarial', anti-inflammatory" and other
pharmacological activities. Further, pyrazolines'",
pyrirnidines+" and 1,5-benzodiazepines9,,0 have
been found to exhibit wide spectrum of biological
activities. On the other hand, different indoles are
also reported to possess hypoglycemic" and
antibacterial" properties. In view of these facts,
and in continuation of our interest in the chemistry
of I, 8-naphthyridines 13-20, we undertook the
synthesis of some' novel spiroheterocyc1es, viz.,
spiro[ indole-pyrazolines], spiro [indole-pyrimidi-
nones], spiro [indole-pyrimidinethiones] and spiro
[indole-I, 5-benzodiazepines] containing 1, 8-
naphthyridine moiety. A few of them are evaluated
for their antibacterial activity.
The key intermediate, 3-acetyl-2-methyl-l, 8-
naphthyridine 1 required for the preparation of the
target compounds, was obtained by the
condensation of 2-aminonicotinaldehyde with
tFor Part I, see ref. 17
acetylacetone in boiling methanol contammg a
catalytic amount of piperidine". The reaction of 1
with different isatins 2 in methanol containing a
few drops of piperidine afforded the corresponding
3-hydroxy- 3-(2-methy 1-1, 8-naphthyridine-3 -car-
bonylmethyl)-indole-2-ones 3, which on dehy-
dration with gl. acetic acid in the presence of cone.
HCl furnished 3-(2-methyl-l, 8-naphthyridine-3-
carbonylmethylene)-indole-2-ones 4 in good yields
(Scheme I).
Cyclocondensation of 4 with hydrazine hydrate
and phenylhydrazine in gl. acetic acid resulted in
the formation of 1'-acetyl-3'-(2-methyl-l, 8-
naphthyridin-3-yl) spiro[3H-indole-3, 5' -pyra-
zoline]-2(1H)-ones 5 and 3'-(2-methyl-l, 8-naph-
thyridin-3-yl)-1' -phenyl-spiro[3H-indole-3, 5'-
pyrazoline]-2(lH)-ones 6, respectively. Treatment
of 4 with urea in methanol containing a few drops
of cone. HCl afforded 4'-(2-methyl-l, 8-
naphthlyridin-3-yl)-15dihydrospiro[3 H-indole-3,
6' -pyrimidine ]-2 2(1H)-diones 7. On the other
hand, interaction of 4 with thiourea in methanolic
KOH yielded 4' -(2-methyl-l, 8-naphthyridin-3-yl)-
2' -thioxo-l', 5' -dihydrospiro[3H-indole-3, 6' -pyri-
midine]-2(1H)-ones 8.
Further, compounds 4 were transformed to 4'-
(2-methyl-l, 8-naphthyridin-3-yl)-1', 3' -dihydro-






Reagents: A = H2 NNH2-~O,CH3COOH for!
= phNHNH2,CH3COOH for ~
B = H2N-CO -N~ • CH30H. cone .Hclior 1
; H2N - CS -NH2 ,CH30H • KOH for !
C = Q _ ph~nvl~nediami~) CH3 COOH for.!
Scheme I
spiro-[3H-indole-3, 2'-1, 5-benzodiazepine ]-2( IH)-
ones 9 by treating them with o-phenylenediamine
in gl. acetic acid.
The structures of 3-9 were confirmed by their
elemental analyses and spectral (lR, IH NMR and
mass) data.
Antibacterial activity
Compounds 4, 6 and 8 were tested for their
antibacterial activity in vitro against Escherichia
coli, Pseudomonas aeruginosa, Bacillus subtilis
and Bacillus mycoides using the filter paper disc
technique of Vincent and Vincent" at 400 and 600
MOGILAIAH et al.: STUDIES IN SPIROHETEROCYCLES: PART n 141
ug/disc concentrations. All the compounds were
active against all the bacteria tested at the
concentration of 400 ug/disc. Compounds 4a, 6e
and 8e were most effective, while 4a, 6e and 8a
were found to have 10V( activity. The remaining
compounds showed moderate antibacterial
activity. In general, compounds 6 and 8 were more
potent than their parent compounds 4. All the
compounds were less active in comparison to
streptomycin which was taken as standard drug.
Experimental Section
Melting points were determined in open
capillaries and are uncorrected. The purity of the
compounds was checked by TLC. IR spectra were
recorded in KBr on a Perkin-Elmer 337
spectrophotometer (vmax in em"), 'H NMR spectra
on a Varian Gemini 200 MHz spectrometer using
TMS as internal standard (chemical shifts in 0,
ppm), and mass spectra on a VG micromass 7070H
instrument at 70 eV.
3-Hydroxy-3-(2-methyl-l, 8-naphthyridine-3-
earbonylmethyl)-indole-2-one 3a. A mixture of 1
(0.01 mole) and 2 (R=H, 0.01 mole) was dissolved
in methanol (50 mL) and piperidine (10 drops) was
added. The reaction mixture was left overnight at
room temperature, then poured onto crushed ice.
The product thus obtained was filtered, washed
with water and recrystallized from methanol to
give 3a, m.p. 180-810, yield 65%; IR (KBr): 3400
(OH), 3250 (NH) and 1723 cm' (C=O); 'H NMR
(DMSO-d6): 0 2.6 (s, 3H, CH3), 3.2 (s, 2H, CH2),
3.5 (s, 1H, OH), 10.05 (s,IH, NH), 8.3 (m, IH, C.-
H), 8.65 (m, IH, Cs-H), 9.1 (m, IH, C7-H) and 6.8-
7.6 (m, 5H, C6-H and 4 Ar-H); MS: mJz 333 (M+,
8%),318 (10), 315 (8),171 (100), 144 (16.4),143
(1J1), i19 (94), 102 (59.7), 92 (64), 91 (17.9) and
164 (32.8).
Compounds 3b-g reported in Table I were
similarly prepared.
3-(2-Methyl-l, 8-naphthyridine-3-earbonyl-
methylene)-indole-2-one 4a. To a solution of 3a
(0.01 mole) in g1. acetic acid (20 mL), cone. HCl
(0.5 mL) was slowly added with constant stirring.
The reaction mixture was heated on a water-bath
for 15 min, allowed to stand at room temperature
for 3 hr and poured onto crushed ice. The solid that
precipitated out was filtered, washed with water
and recrystallized from methanol to afford 4a, m.p.
238-39°, yield 80%; IR (KBr): 3240 (NH), 1710
(C=O) and 1605 em' (C=C); 'H NMR (DMSQ-d6):
o 2.55 (s, 3H, CH3), 9.8 (s, IH, NH), 8.2 (m, IH,
C.-H), 8.7 (m, 1H, Cs-H), 9.2 (m, 1H, C7-H) and
6.6-7.7 (m, 6H, C6-H,-CH-C and 4 Ar-H); MS: m
/z 315 (M+; 16.4%), 286 (7.5), 171 (8.9), 144
(100), 143 (17.9), 119 (15), 105 (13.4) and 102
(10).
Compounds 4b-g reported in Table I were
similarly prepared.
l' -Acetyl-3' -(2-methyl-l,8-naphthyridin-3-yl)-
spiro [3H-indole-3,S' -pyrazoline)-2(1H)-one Sa.
A mixture of 4a (0.01 mole) and hydrazine hydrate
(0.015 mole) in g1. acetic acid (25 mL) was
refluxed for 5 hr, cooled and poured into ice-cold
water. The separated solid was filtered, washed
with water and recrystallized from methanol to
yield Sa, m.p. 248-49° (d), yield 60%; IR (KBr):
3220 (NH), 1715 (C=O) and 1615 cm' (C=N);
MS: mJz 371 (M+, 13.4%), 330 (12), 329 (10.4),
315 (55), 198 (50.8), 169 (25), 143 (34), 132
(53.7), 119 (20.9), 105 (82), 104 (100) and 77
(68.7).




6a. A mixture of 4a (0.01 mole) and
phenylhydrazine (0.015 mole) in g1.acetic acid (30
mL) was heated under reflux for 4 hr. The cold
reaction mixture was diluted with water and the
solid that separated out was filtered, washed with
water and recrystallized from g1. acetic acid to
furnish 6a, m.p. 254-56°, yield 64%; JR (KBr):
3400 (NH), 1710 (C=O) and 1615 cm' (C=N); 'H
NMR (DMSO-d6): 02.6 (s, 3H, CH3), 3.1(s, 2H,
CH2), 10.8 (s, IH, NH), 8.4 (m, IH, C4-H of
naphthyridine moiety), 8.8 (m, IH, Cs-H of
naphthyridine moiety), 9.05 (m, IH, C7-H of
naphthyridine moiety) and 6.8-7.7 (m, 10H, C6-H
ofnaphthyridine moiety and 9 Ar-H); MS: mJz 405
(M+, 12%), 390 (10.4), 315 (34), 275 (41.8), 262
(9), 236 (68.7), 169 (12), 143 (40.3), 132 (44.8),
119 (16.4~, 105 (38.8), 104 (47.8) and 77 (100).
Compounds 6b-g reported in Table I were
similarly prepared.
4'-(2-Methyl-l, 8-naphthyridin-3-yl)-l', 5'-
dihydrospiro (3H-indole-3, 6'-pyrimidine) 2,2'-
(lH)-dione 7a. To a mixture urea (0.016 mole)
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Table I-Characterization data of compounds 3-9
Compd+ R m.p. Yield Mol. formula Found (%) (Calc.)
(0C) (%) C H N
3. H 180-81 65 C,JlI5NP~ 68.7 4.6 12.7
(68.5 4.5 12.6)
3b 5-CH) 176-77 78 CJlI7N)O) 69.4 4.8 12.3
(69.2 4.9 12.1)
3c 7-CH) 218-19 73 C2Ji17N1Ol 69.3 4.8 12.3
(69.2 4.9 12.1)
3d 5-OCH) 220-22 76 C2Ji17N)04 66.3 4.9 11.5
(66.1 4.7 11.6)
3e 5-CI 252-53 80 C,JI'4Np)CI 62.3 3.9 11.6
(62.1 3.8 11.4)
3f 7-CI 168-69 75 C,9H'4N)O)CI 62.4 3.9 11.5
(62.1 3.8 11.4)
3g 5-Br 225-27 74 C1JlI4Np)Br 55.5 3.5 10.4
(55.3 3.4 10.2)
4a H 238-39 80 CI9H13N)02 72.5 4.2 13.5
(72.4 4.1 13.3)
4b 5-CH) 190-91 86 C2JilSN302 72.7 4.7 12.6
(72.9 4.6 12.8)
4c 7-CH) 242-43(d) 82 C2Ji,sNP2 72.8 4.7 12.7
(72.9 4.6 12.8)
4d 5-0CH) 257-59(d) 85 C2Ji,sN)O) 69.8 4.5 12.4
(69.6 4.3 12.2)
4e 5-CI 200-02 90 C,JlI2NP2C1 65.5 3.5 12.2
(65.3 3.4 12.0)
4f 7-CI 228-29 83 C,JlI2NP2C1 65.4 3.6 12.1
(65.3 3.4 12.0)
4g 5-Br 236-37 84 C'9H'2N)02Br 57.9 3.2 10.8
(57.7 3.0 10.7)
Sa H 248-49(d) 60 C2,H'7NS02 67.4 4.8 18.7
(67.2 4.6 18.9)
5b 5-CH3 220-21 68 C2zH'9NSOZ 68.8 4.7 18.4
(68.6 4.9 18.2)
5c 7-CHl 160-62 62 CZ2HI9Ns02 68.9 4.8 18.3
(68.6 4.9 18.2)
Sd 5-OCH) 286-87(d) 66 C22H'9NSOJ 65.6 4.8 17.7
(65.8 4.7 17.5)
Se 5-CI 228-29 70 C2IH'6Ns02CI 62.4 4.1 17.4
(62,2 4.0 17.3)
Sf 7-CI 208-09 64 Cz,H'6Ns02Cl 62.3 4.2 17.5
(62.2 4.0 17.3)
S~ 5-Br 214-15 65 C2,H'6Ns02Br 56.3 3,8 15.7
(56,~ 3.6 15,6)
6a H 254-56 64 CzsH,9'~sO 74,3 4.9 17,5
(74,1 4,7 17.3)
6b 5-CH) 170-71 75 C26Hz,NsO 74,2 5.1 16.9
(74.5 5.0 16.7)
6c 7-CH) 188-89 70 Cz6HzINsO 74,4 5.2 16.8
(74.5 5.0 16.7)
6d 5-OCH) 272-74(d) 76 C26H2,NsOz 71.9 4.9 16.3
, (71.7 4.8 16.1)
6e 5-CI 218-19 80 C2sHIIN5OCI 68.4 4.3 15,8
(68.3 4,1 15.9)
6f 7-CI 252-53 74 C2sHilNsO Ci 68,5 4,2 15,7
(68.3 41 15,9)
(Contd.)
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Table I~haracterization data of compounds 3-9-Contd.
Ccmpd" R m.p. Yield Mol. fonnula Found (%) (Calc.)
(0C) (%) C H N
6& 5-Br 24S-49 7S ClSH.1NsOBr 62.2 3.S 14.7
(62.0 3.7 14.5)
7. H 272-73 55 CJi.sNsOz 67.3 4.3 19.5
(67.2 4.2 19.6)
7b 5-CH) 292-94(d) 6S Cz.H.7NsOz 67.6 4.7 IS.S
(67.9 4.6 IS.9)
7c 7-CH) 2S0-S1(d) 62 CZ.H.7NsOz 67.7 4.S IS.7
(67.9 4.6 IS.9)
7d 5-OCH) 267-6S 67 Cz.H.7NsO) 65.3 4.5 IS.2
(65.1 4.4 IS.1)
7e 5-C1 254-55 70 CJi.4NS01Ci 61.5 3.7 17.S
(61.4 3.6 17.9)
7f 7-C1 274-75 65 CJi.4NSOzC1 61.6 3.7 17.7
(61.4 3.6 17.9)
71 5-Br 2S5-S7(d) M CJi.4NSOzBr 55.3 3.4 16.3
(55.0 3.2 16.1)
Sa H 260-61 5S CJi.sNsOS 64.5 4.2 IS.9
(M.3 4.0 IS.S)
8b 5-CH) 270-7 I(d) 72 Cz.H.7NsOS 65.2 4.6 IS.3
(65.1 4.4 IS.1)
Ie 7-CH) 202-03 66 Cz.H.7NsOS 65.3 4.5 IS.2
(65.1 4.4 IS.I)
lei 5-OCH) 256-57 6S ClIH.7NsOzS 62.3 4.3 17.6
(62.5 4.2 17.4)
Ie 5-C1 272-74(d) 75 CJi.4NsOSCl 59.3 3.5 17.0
(59.0 3.4 17.2)
Sf 7-CI 260-61 70 CJi.4NsOSCI 59.2 3.6 17.1
(59.0 3.4 17.2)
8g 5-Br 242-43 72 CJi.4NsOSBr 53.4 3.2 15.7
(53.1 3.1 15.5)
9. H 27S-S0 62 ClSH.,NsO 74.2 4.S 17.5
(74.1 4.7 17.3)
9b 5-CH) 230-31 75 Cz6H2INsO 74.4 5.1 16.S
(74.5 5.0 16.7)
9c 7-CH) 24S-49 70 Cz6H2INsO 74.3 5.2 16.9
(74.5 5.0 16.7)
9d 5-OCH) 262-63 74 CZ6Hz.NsOz 71.9 4.7 16.2
(71.7 4.8 16.1)
ge 5-CI 234-35 78 CzsH.,NPCI 68.5 4.2 15.8
(68.3 4.1 15.9)
9f 7-CI 272-74(d) 68 CzsH.,NsOCI 68.4 4.2 15.8
(68.3 4.1 15.9)
9g 5-Br 258-59 72 CzsHIINsOBr 62.3 3.9 14.7
(62.0 3.7 14.5)
(d) = decompose
•All the compounds were crystallized from methanol except 6a-g and 9a-g which were recrystallized from acetic acid.
and methanol (20 mL) was added enough cone. from methanol to give 7a, m.p. 272-73°, yield
HCI to clear the solution, and then added 4a (0.01 55%; IR (KBr): 3416 (NH), 1716 (C=O) and 1622
mole). The reaction mixture was refluxed on a cm' (C=N); MS: m1z 357 (M+, 9.5%), 300 (40),
water-bath for 5 hr, concentrated, cooled and 267 (43.6), 197 (21.8), 169 (8.5), 143 (27), 132
treated with ammonia solution. The resultant soild (23.6), 119 (25), 117 (100), 105 (48), 104 (25) and
was filtered, washed with water and recrystallized 91 (63.6).
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Compounds 7b-g reported in Table I were
similarly prepared.
4' -(2-Methyl-l ,8-naphthyridin-3-yl)-2' -thioxo-
l' ,5' -dihydrospiro [3H-indole-3,6' -pyrimidine]-2
(lH)-one 8a. A mixture of 4a (O.Olmole), thiourea
(0.01 mole), KOH (0.1 g), water (2 mL) and
methanol (30 mL) was refluxed for 4 hr. The
precipitate obtained after dilution with water was
filtered, washed with water and recrystallized from
methanol to afford 8a, m.p. 260-61°, yield 58%; IR
(KBr): 3410 (NH), 1710 (C=O) and 1185 cm'
(C=S); IH NMR (DMSO-d6): 8 2.5 (s, 3H, CH3),
3.0 (s, 2H, CH2), 1] .05 (s, lH, indole NH), 8.2 (m,
IH, C4-H ofnaphthyridine moiety), 9.0 (m, lH, C7-
H of naphthyridine moiety) and 6.7-7.8 (m, 6H,
C6-H of naphthyridine moiety, l'HI of pyrimidine
ring and 4 Ar-H); MS : m/z 373 (M+, 18%), 256
(26.9), 169 (12), 160 (37.3), 143 (21), 132 (44.8),
119 (19.4), 105 (40), 104 (64), 91 (15) and 64
(l00).
Compounds 8b-g reported in Table I were
similarly prepared.
4'-(2-Methyl-1 ~ 8-naphthyridin-3-yl)-1', 3'-
dihydrospiro(3H-indole-3, 2' -1, 5-benzodia-
zepine)-2 (lH)-one 9a. A mixture of 4a
(O.Olmole) and a-phenylenediamine (0.01 mole) in
gl. acetic acid (30 ml.) was refluxed for 6 hr,
cooled and poured onto crushed ice with vigorous
stirring. The precipitate thus obtained was filtered,
washed with water and recrystallized from gl.
acetic acid to furnish 9a, m.p. 278-80°, yield 62%;
lR (KBr): 3250 (NH), 1715 (C=O) and 1610 cm'
(C=N); MS : m/z 405 (M+, 15%), 300 (7.8), 271
(15.6),247 (70), 220 (14), 219 (100), 143 (12.5),
119 (32), 117 (68.8),105 (42) 104 (28) and 91
(73.4).
Compounds 9b-g reported in Table I were
similarly prepared.
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